Remove 2023 Remove Patent Remove Patent Application Remove Patent Drafting
article thumbnail

CALL FOR TRYOUTS – USPTO National Patent Application Drafting Competition

IPilogue

2021-2022 was a big year for the Osgoode’s mooting team entry for the USPTO National Patent Application Drafting Competition. We invite you to participate in the tryouts for the 2022-2023 National Patent Application Drafting Competition ! About the National Patent Application Drafting Competition.

article thumbnail

[Sponsored] Registration Deadline Extended for the “Comprehensive Course on Patents” Organized by The IP Press In Collaboration with S. Majumdar & Co. (October 5-November 23)

SpicyIP

We are pleased to bring to you this sponsored post by IP Press on the extension of the registration deadlines for their Comprehensive Course on Patents, in collaboration with S. The IP Press presents the third cohort of the Comprehensive Course on Patents. Majumdar & Co.who are experts in the field of Patents.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

[Webinar] Patent Fundamentals Bootcamp 2023: An Introduction to Patent Drafting, Prosecution, and Litigation - September 12th, 8:00 am - 5:00 pm PDT

JD Supra Law

PLI’s Patent Bootcamp offers an exceptionally comprehensive and interactive environment for attendees who want to learn the basics of patent application preparation, claims drafting, and prosecution, as well as recent developments in the law. Instructed by leading patent. By: Practising Law Institute (PLI)

article thumbnail

IP strategy for AI-assisted drug discovery

The IPKat

An important question for such companies is when, and even if, to file patents for this IP. Patent protection for a new molecule entering clinical trials is how innovator pharmaceutical companies seek to ensure a return of investment for the millions of dollars required to take the drug through to market. Alfie (a.k.a.

IP 56
article thumbnail

EPO maintains ST.26 sequence listing requirement for divisionals but compromises on excess page fees

The IPKat

The applicant may therefore be required to convert the ST.25 25 sequence listing of a parent application into a ST.26 DNA Maine Coon The Institute of Professional Representatives before the European Patent Office (epi) raised the added matter issue with the EPO last year ( IPKat ). Patent offices have discretion over whether ST.26

article thumbnail

AI Visualize and the Eligibility of Innovative AI Systems

Patently-O

Datzov, The Role of Patent (In)Eligibility in Promoting Artificial Intelligence Innovation , 92 UMKC L. 1, 4 (2023). AI Visualize had asserted four related patents that facilitated use of a low-bandwidth web portal for visualizing 3D/4D medical scans. Patent Nos. .” Nikola L. AI Visualize, Inc.

article thumbnail

Adding matter by cherry-picking from separate embodiments: Philip Morris v BAT ([2023] EWHC 2616 (Pat))

The IPKat

In the recent UK case of Philip Morris v BAT [2023] EWHC 2616 (Pat) , His Honour Justice Hacon (Hacon HHJ) considered the standard for invalidity due to added matter. Invalidity in view of added matter is a common patent pitfall in Europe ( IPKat ). Final thoughts: Added matter versus patent profanity? Smoke Free World. "

Invention 111